The cataract-causing mutation G75V promotes γS-crystallin aggregation by modifying and destabilizing the native...

Area of Science:

• Ophthalmology
• Biochemistry
• Structural Biology

Background:

• Congenital cataract is a primary cause of childhood blindness globally.
• Hereditary cataracts are often linked to mutations in crystallin proteins, but mechanisms remain unclear.
• GammaS-crystallin (γS-crystallin) plays a crucial role in maintaining lens transparency.

Purpose of the Study:

• To investigate the structural and functional consequences of the G75V mutation in γS-crystallin.
• To understand how this mutation affects protein stability and aggregation propensity.
• To explore potential therapeutic interventions, such as inhibition by alphaA-crystallin.

Main Methods:

• Spectroscopic techniques (fluorescence, circular dichroism) to analyze protein structure and stability.
• Assays to measure protein aggregation under various stress conditions (heat, chemical denaturation, UV irradiation).
• Comparative studies of wild-type (WT) γS-crystallin and the G75V mutant, including co-incubation with αA-crystallin.

Main Results:

• The G75V mutation significantly altered the tertiary structure of γS-crystallin, increasing solvent accessibility and hydrophobic exposure.
• Mutant γS-crystallin exhibited reduced stability and higher susceptibility to denaturation by heat, guanidine hydrochloride, and acid.
• The G75V mutant showed increased propensity for aggregate formation upon denaturation, which was more effectively inhibited by αA-crystallin compared to WT protein.

Conclusions:

• The G75V mutation induces structural aberrations in γS-crystallin, leading to decreased stability and enhanced aggregation.
• These molecular changes provide a mechanistic link between γS-crystallin mutations and the development of hereditary cataracts.
• AlphaA-crystallin demonstrates potential as a therapeutic agent by inhibiting the aggregation of mutated γS-crystallin.